ARTeSYN Biosolutions, the manufacturer of single-use solutions for biopharma processing, is to significantly expand its Waterford operations by adding 50 new roles in Production, Engineering, Customer Service and Research & Development over the next 3 years at its facilities in the Six Cross Roads Business Park, Waterford.
The expansion of the site increases the company’s consumables and overall production capacity by an additional 2200 ft². The company which has invested over €1M in its manufacturing & cleanroom facilities currently employs 24 people in Waterford. Due to the increase in demand for its components & systems by global companies in the biopharma sector, ARTeSYN Biosolutions has identified Waterford as a key site from which to supply its growing customer base.
Jonathan Downey, Operations Director of ARTeSYN’s Waterford Headquarters said “This is a great development for ARTeSYN Biosolutions and marks a significant expansion of our Waterford manufacturing operations which allows us to ensure that we can increasingly support our global biotechnology customers in the development and production of next generation therapies to treat and cure serious illnesses. Having our Global Headquarters in Waterford illustrates the confidence that companies like ours, with a global footprint, have in Ireland. Our expansion plans, although ambitious, are achievable through the support of the Irish manufacturing ecosystem and we are looking forward to the further development of our manufacturing operations at our Irish and European facilities.”
Michael Gagne, Founder & CXO of ARTeSYN Biosolutions commented “As we expand our global manufacturing capabilities to ensure our increasing ability to enable abundance in medicine, we are pleased to announce the expansion of our Irish facilities. ARTeSYN Biosolutions has been committed to the establishment and development of our Waterford Headquarters and we are excited about our expansion and increasing development of our operations in Ireland and beyond over the coming months and years.”
About ARTeSYN Biosolutions:
ARTeSYN Biosolutions, a privately-held company, is a fast-expanding brand providing single-use solutions to the biotechnology & cell and gene therapy market. ARTeSYN has several locations in the US and over the last few years has expanded to Ireland, Estonia & Asia. The global team shares 30+ years of experience in building simple and effective components and systems. Our goal is to enable not 10%, but 10x more efficient manufacturing and ultimately ease access to essential medicines globally. In essence, we have created a series of solutions targeting the voids and expanding the possibilities in the existing single-use space. Our single-use valves, fully disposable valve liners, instruments, flow management technology, and automated process systems, enable creative approaches in their most advanced forms for common industry problems.
For more information about the company, visit:www.artesynbiosolutions.com